There is no one reason why some people get Alzheimer’s and others do not. Most scientists point to genetics and lifestyle as the main…
Any Alzheimer’s drug under development has a complicated journey from formulation to clinical trials to potentially getting in the hands of patients. We spoke…
While taking a tumble might sound harmless enough, falls are a common threat to adults over 65—about one-third experience a fall over the course…
Alzheimer’s is not a disease that just affects memory, as many people who haven’t had firsthand experience might assume. Alzheimer’s affects your entire body,…
The first thing most Alzheimer’s patients do when they get a diagnosis? Pretend like nothing happened. “They call it the Alzheimer’s closet,” said 54-year-old…
In a mice study, researchers have developed an antibody to clears amyloid plaques, a hallmark of Alzheimer’s. Most scientists believe that Alzheimer’s is caused…
A new report that a simple daily dose of ibuprofen could eradicate Alzheimer’s is circling the web. While the study that has sparked this…
Treading into ethically and legally uncertain territory, a New York end-of-life agency has approved a new document that lets people stipulate in advance that…
Researchers have been searching for ways to restore memories lost Alzheimer’s. What if instead of restoration, we rewired the brain itself? For years, researchers…
In a society where eating three large meals at the beginning, middle and end of the day is the norm, not eating seems like an…
As scientists continue to search for a cure for Alzheimer’s, a study from University of Texas Southwestern suggests that a drug might already exist…
Research is underway to study the effects of lifestyle in improving our health and reducing the risk of Alzheimer’s. For a long time, Alzheimer’s…
Could nurses with better training change the way dementia patients recover from surgery? A new study published in the Journal of the American Geriatrics…
As Alzheimer’s diagnoses rise and treatments in clinical trials continue to stall, the cost of the disease is going up—to the tune of $277…
Experimental drugs for Alzheimer’s disease have a 99.6 percent failure rate. Not such a great track record. But, according to an expert in the…